Evaluation of brain lesion distribution criteria at disease onset in differentiating MS from NMOSD and MOG-IgG-associated encephalomyelitis

被引:31
|
作者
Hyun, Jae-Won [1 ]
Huh, So-Young [2 ]
Shin, Hyun-June [1 ]
Woodhall, Mark [3 ,4 ]
Kim, Su-Hyun [1 ]
Irani, Sarosh R. [3 ,4 ]
Lee, Sang Hyun [5 ]
Waters, Patrick [3 ,4 ]
Kim, Ho Jin [1 ]
机构
[1] Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, 323 Ilsan Ro, Goyang 10408, South Korea
[2] Kosin Univ, Coll Med, Dept Neurol, Busan, South Korea
[3] Nuffield Dept Clin Neurosci, Autoimmune Neurol Grp, Oxford, England
[4] Univ Oxford, Oxford, England
[5] Natl Canc Ctr, Res Inst & Hosp, Dept Radiol, Goyang, South Korea
基金
新加坡国家研究基金会;
关键词
Multiple sclerosis; neuromyelitis optica spectrum disorder; brain; MRI; SPECTRUM DISORDER; MULTIPLE-SCLEROSIS; DISTINCTION; DIAGNOSIS; MRI;
D O I
10.1177/1352458518761186
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We aimed to evaluate the utility of the recently described brain lesion distribution criteria to differentiate multiple sclerosis (MS) from aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein immunoglobulin G-associated encephalomyelitis (MOG-EM) at disease onset in an Asian cohort. Methods: A total of 214 patients who fulfilled the published criteria for MS, NMOSD, or MOG-EM and underwent brain magnetic resonance imaging (MRI) within 3 months of disease onset were enrolled. The brain lesion distribution criteria were defined as the presence of a lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe, or an S-shaped U-fiber lesion, or a Dawson's finger-type lesion. Results: Brain lesions were identified in the initial MRI scans of 166/214 patients. The distribution criteria were applied to these scans (MS (n = 94), NMOSD (n = 64), and MOG-EM (n = 8)). The sensitivity, specificity, and positive and negative predictive values of the criteria for MS versus NMOSD were 79.8%, 87.5%, 90.4%, and 74.7%, and for MS versus MOG-EM these were 79.8%, 100%, 100%, and 29.6%, respectively. Conclusion: These findings suggest that the brain lesion distribution criteria are helpful in distinguishing MS from NMOSD and MOG-EM in an Asian population, even at disease onset.
引用
收藏
页码:585 / 590
页数:6
相关论文
共 7 条
  • [1] Evaluation of brain and spinal cord lesion distribution criteria at disease onset in distinguishing NMOSD from MS and MOG antibody-associated disorder
    Cai, Meng-Ting
    Zheng, Yang
    Shen, Chun-Hong
    Yang, Fan
    Fang, Wei
    Zhang, Yin-Xi
    Ding, Mei-Ping
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (06) : 871 - 882
  • [2] Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype
    Otto, Ferdinand
    Moser, Tobias
    Feige, Julia
    Seiberl, Michael
    Bieler, Lara
    Sellner, Johann
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 42
  • [3] Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
    Jurynczyk, Maciej
    Tackley, George
    Kong, Yazhuo
    Geraldes, Ruth
    Matthews, Lucy
    Woodhall, Mark
    Waters, Patrick
    Kuker, Wilhelm
    Craner, Matthew
    Weir, Andrew
    DeLuca, Gabriele C.
    Kremer, Stephane
    Leite, Maria Isabel
    Vincent, Angela
    Jacob, Anu
    de Seze, Jerome
    Palace, Jacqueline
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (02) : 132 - 136
  • [4] Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders
    Lopez-Chiriboga, A. Sebastian
    Majed, Masoud
    Fryer, James
    Dubey, Divyanshu
    McKeon, Andrew
    Flanagan, Eoin P.
    Jitprapaikulsan, Jiraporn
    Kothapalli, Naga
    Tillema, Jan-Mendelt
    Chen, John
    Weinshenker, Brian
    Wingerchuk, Dean
    Sagen, Jessica
    Gadoth, Avi
    Lennon, Vanda A.
    Keegan, B. Mark
    Lucchinetti, Claudia
    Pittock, Sean J.
    JAMA NEUROLOGY, 2018, 75 (11) : 1355 - 1363
  • [5] Development and validation of a simple and practical method for differentiating MS from other neuroinflammatory disorders based on lesion distribution on brain MRI
    Patel, J.
    Pires, A.
    Derman, A.
    Fatterpekar, G.
    Charlson, R. E.
    Oh, C.
    Kister, I.
    JOURNAL OF CLINICAL NEUROSCIENCE, 2022, 101 : 32 - 36
  • [6] Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients
    Carnero Contentti, Edgar
    Marques, Vanessa Daccach
    de Castillo, Ibis Soto
    Tkachuk, Veronica
    Barreira, Amilton Antunes
    Caride, Alejandro
    Castillo, Maria C.
    Cristiano, Edgardo
    Cruz, Camila de Aquino
    Diegues Serva, Gabriel Braga
    dos Santos, Antonio Carlos
    Labarca, Rossanny
    Moreira, Carolina Lavigne
    Lopez, Pablo A.
    Miguez, Jimena
    Molina, Omaira
    Pablo Pettinicchi, Juan
    Ignacio Rojas, Juan
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (08) : 945 - 954
  • [7] Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis
    Bensi, C.
    Marrodan, M.
    Gonzalez, A.
    Chertcoff, A.
    Osa Sanz, E.
    Chaves, H.
    Schteinschnaider, A.
    Correale, J.
    Farez, M. F.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2018, 25 : 246 - 250